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Abstract. Recurrent abdominal pain (RAP) in children is defined as at least three episodes of pain that occur over at 
least three months and affect the child's ability to perform normal activities. The prevalence of recurrent abdominal 
pain in a population of schoolchildren varies from 10% to even 45%. Pituitary disorders are rarely considered as 
causative factor in children with abdominal pain, especially in absence of midline facial defects and in case of 
emergency, when growth monitoring is neglected or not performed carefully. Herein we report an unusual case of 
RAP caused by secondary adrenal insufficiency. An 8-year-old girl was hospitalized repeatedly because of RAP. 
Biological parameters including white blood cell count, hemoglobin value, C-reactive protein, glucose, electrolytes 
were within the normal range. Low cortisol combined with low ACTH values was the clue for diagnosis. The magnetic 
resonance imaging (MRI) of the pituitary region revealed anterior pituitary hypoplasia and pituitary stalk 
interruption. To the best of our knowledge, this is the first report of child with RAP caused by pituitary disorder. 
Possible inherited, autoimmune and post-traumatic causative factors are discussed. 
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Recurrent abdominal pain (RAP) in children is defined as 
at least three episodes of pain that occur over at least three 
months and affect the child's ability to perform normal 
activities [1]. It is one of the commonest reasons for refer-
ral to pediatrician and pediatric gastroenterologist, as well 
to pediatric surgeon. Almost all children have abdominal 
pain at one time or another. The prevalence of recurrent 
abdominal pain in a population of schoolchildren varies 
from 10% to even 45% [1, 2]. Mostly, it is not caused by a 
serious medical problem, and has transient nature. How-
ever, a vast majority of abdominal and non-abdominal 
causes could be involved, classified as organic or non-or-
ganic (functional, like “visceral hyperalgesia”) [3). It is 
noteworthy to say that abdominal pain can be a sign of 
serious illness that seeks urgent and specific treatment. We 
here report an unusual case of recurrent abdominal pain 
accompanied by growth failure , fatigue, weakness and 
weight loss, caused by endocrine disorder: pituitary-ad-
renal axis insufficiency. 
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Case Report 
Initial examination 
In August 2018, an 8-year-old girl was referred to Pedi-
atric Clinic of Nis because of acute abdominal pain with 
formed stools without hematochezia. Abdominal pain 
started ten days before admission. It was located in 
periumbilical region and was more prominent in the 
right iliac fossa, without vomiting and fever. Neither 
urinary disorders nor weight loss were documented on 
first admission. Her examination otherwise was normal. 
She was born at term after an uneventful pregnancy; 
birth weight was 3.150 g (P25), birth length of 54.0 cm 
(P90) on Fenton growth charts. Apgar score was not 
available, but spontaneous breathing without cyanosis 
or jaundice was documented. No dysmorphic features 
were noticed. She was breast fed from birth until the age 
of 10 months when gluten was introduced into the diet 
without any adverse gastrointestinal effect. At the age of 
3 years she experienced head injury, estimated as non-
serious. Both parents were healthy and unrelated, with 
no history of endocrine or autoimmune diseases and 
with normal pubertal development. 
She was proportionally short; her height of 121cm 
was -1.88 SD (P3) for her Chronological Age (CA), her 
Height Age (HA) corresponded to 7 years, and her Body 
Mass (BM) of 22 kg was 0.6 kg below her ideal weight-
for-height. Her BMI was 21.5 kg/m2 (P27). Bone age 
was retarded and corresponded to 5.5 years. No signs of 
puberty were registered. Growth records before 8 years 
of age were unavailable. 
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A pediatric surgeon reviewed and observed her for 
three days. A physical examination revealed a distended 
abdomen without defense or masses. Bowel sounds 
were present without organomegaly. An X-ray of ab-
domen showed only signs of constipation. The ab-
dominal ultrasound (US) was reported as normal. Con-
clusion: no surgical cause of abdominal pain was dis-
covered. 
First hospitalization 
An investigation of pediatric gastroenterologist was 
indicated. The girl was referred again to Pediatric Clinic 
for further investigation. Complete systemic examina-
tion showed no pathological findings. Biological pa-
rameters including white blood cell count, hemoglobin 
value, C-reactive protein, glucose, electrolytes were 
within the normal range. Stool cultures were negative. 
Viral tests (CMV, EBV, HSV1, and Coxsackie virus) 
were also negative. Furthermore, serum anti-tissue 
transglutaminase (tTG) antibodies (immunoglobulin 
IgA-tTG = 0.1 U/mL, normal values <10 U/mL), ASCA 
IgA and IgG were negative. Fecal calprotectin test was 
within normal range. MSCT of abdomen and pelvis was 
performed and it came back normal. During hospitali-
zation she also complained of headaches without vom-
iting. An examination of pediatric neurologist showed 
no structural causes identified of present headaches. She 
was treated by conservative management (rehydration 
and analgesia). Conclusion: no structural cause identi-
fied of abdominal pain. 
The patient was discharged from the hospital with 
advice to use antispasmodic therapy in abdominal pain 
episodes. 
Second hospitalization 
Two weeks later, the girl was urgently admitted to Pedi-
atric Clinic due to the worsening of symptoms. On ex-
amination, she complained of severe abdominal pain 
located again periumbilically and more to the right iliac 
fossa. A few days before admission, she was febrile to 
39
0
 C. The pain occurred every day in the afternoon or 
early evening with vomiting. She had regular stools. 
Weight loss of about 3.5 kg was reported during more 
than a month. No history of polydipsia, polyuria and 
heat/cold intolerance was reported. She looked unwell 
and had clinical dehydration. Evaluation of her vital signs 
revealed slightly decreased blood pressure at 95/65mmHg 
and normal heart rate to 87/min. Her respiratory rate was 
26 breaths/min. The girl was awake and oriented but 
appeared weak and fatigued. Her skin turgor was reduced 
and capillary refill time was 2 seconds. In the right frontal 
part of the scalp we noticed a white scar-like linear 
change of 2.5 cm in length. The neck was supple with no 
goiter or adenopathy. The lungs were clear to auscultation 
and the heart revealed no murmurs. Bowel sounds were 
audible with normal genitals and no deformities in 
extremities were observed. 
Laboratory investigations were within the normal 
range including electrolytes. Blood film was reported as 
normal. Her urine was clear on dipstick testing; urinary 
microscopy and culture were negative. An abdominal 
ultrasound (US) was requested and was reported as 
normal. Initially, the girl was treated by conservative 
management (IV rehydration with crystalloids) and an-
algesia. During hospitalization, she received intravenous 
antibiotics and corticosteroids. A pediatric surgeon was 
consulted and he did not find any surgical cause of the 
abdominal pain. This time he advised endoscopic ex-
amination. Fecal calprotectin test was positive (1490 µg/g), 
but the control calprotectin value was within normal range 
(26.6 µg/g). Upper endoscopy and colonoscopy revealed 
normal bowel structure. MRI enterography was performed 
and was reported as normal without any sign of 
inflammatory bowel disease (IBD). Repeatedly, the 
gastrointestinal causes of abdominal pain were excluded. 
However, the clinical picture persisted despite adequate 
conservative management and analgesia. It is noteworthy 
to say that symptoms aggravated during afternoon. 
What could be the cause of recurrent abdominal pain 
in our patient? We considered: 
 Functional abdominal pain in which no structural 
causes are identified in 90% of cases 
 Surgical disorders;  
 Gastrointestinal disorders;  
 Systemic disorders; 
 Renal disorders; 
 Hepatobiliary/pancreatic disorders; 
 Neurological/Psychosocial disorders; 
 Malignant diseases; 
 Endocrine disorders 
 Metabolic disorders - porphyria. 
Then we focused our investigation on excluding 
possible endocrine causes of this abdominal pain. De-
spite the normal blood glucose and electrolytes, the en-
docrinologist suggested the possibility of adrenal insuf-
ficiency and advised examination of hormonal status 
including TSH, FT4, PRL, cortisol and ACTH. 
Extremely low levels of cortisol (20nmol/l) and in-
appropriately low ACTH (1.8 pg/ml) were found, re-
vealing secondary adrenal insufficiency (Table1). Lev-
els of TSH, FT4, and PRL were within normal range. 
Repeated check of morning cortisol and ACTH level 
confirmed secondary adrenal insufficiency. Short ACTH 
stimulation test was not done because of lack of the test 
dose and even more because of the necessity of urgent 
substitution therapy. 
Table 1 Confirmatory serum testing for secondary adrenal 
insufficiency 
Test Patient's result Normal value 
ACTH (pg/ml) 1.8pg/ml (7.20-63.30) 
Cortisol (nmol/l) 20.0 nmol/l (166.0-507.0) 
Cortisol in ACTH 
stimulation test 
Non available > 550 
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The magnetic resonance imaging (MRI) of the pituitary 
region showed the anterior pituitary hypoplasia and 
pituitary stalk interruption (Fig. 1 and Fig. 2). We con-
cluded that the cause of adrenal insufficiency in this case is 
of pituitary origin: pituitary hypoplasia (congenital or 
acquired) which resulted in partial hypopituitarism, pre-
senting as RAP caused by secondary adrenal insufficiency. 
The patient’s abdominal symptoms resolved imme-
diately after introduction of the first doses of substitu-
tion therapy with higher physiological doses of hydro-
cortisone. Hydrocortisone is given in 3 separate doses 
with a typical total daily dose of 15mg/m²; 7.5 mg, in 
the morning, 2.5 mg at lunchtime and early evening 
(6:00PM). During acute febrile illness or in case of 
trauma, the parents were advised to double the hydro-
cortisone dose. In case of vomiting and diarrhea, the 
advice was to triple the daily dose. In the later occasion, 
it would be necessary to give intravenous hydrocorti-
sone and crystalloids [4].  
Evaluation of the treatment effect 
Two weeks later, the girl was admitted for evaluation of 
the replacement therapy quality. Her abdominal symp-
toms resolved with implementation of hydrocortisone, 
but the fatigue persisted. Hypotension and headache 
were still reported. 
Control hormonal status showed still low values of 
morning cortisol and ACTH, low levels of PRL and 
euthyroid state. The patient’s gonadotropin levels corre-
sponded to prepubertal values. Hydrocortisone therapy 
was corrected and increased to a total daily dose of 
18 mg/m²: 10mg in early morning, 5mg at lunchtime 
and 2.5 mg at early evening (6:00 PM), with advice of 
dose adjustment as above.  
Since the patient’s height of 120.5cm has been on P3 
for her Chronological Age (CA) in discordance with 
MPH (Mean Predicted Height calculated being on P75) 
and the fact that some complaints could be attributed to 
growth hormone deficiency (GHD), recombinant 
growth hormone was introduced without previous test-
ing of somatotropic axis. We made this decision based 
on documented structural pituitary stalk lesion and ante-
rior pituitary hypoplasia. IGF1 determination was not 
available. Growth hormone deficiency was assumed as 
certain and under such circumstances GH stimulation 
tests are unnecessary, and even dangerous [511]. Intro-
duction of GH therapy led to complete patient’s recov-
ery. Further follow-up and growth will eventually un-
mask other pituitary deficiencies.  
Discussion 
Pituitary disorders are rarely considered as a causative 
factor in children with abdominal pain, especially in 
absence of midline facial defects and in cases of emer-
gency, when growth monitoring is neglected or not per-
formed carefully. In our experience, pediatric gastroen-
terologists do care about neighboring organ status (testis 
torsion or basal pneumonia), but with the exception of 
DKA (Diabetic Ketoacidosis) or CAH (Congenital 
Adrenal Hyperplasia), they do not consider any other 
endocrine cause of abdominal pain (hypopituitarism, 
pheochromocytoma or hyperparathyreodismus i.e.). 
Herein we reported an unusual case of RAP caused by 
secondary adrenal insufficiency. Low cortisol combined 
with low ACTH values was of diagnostic value. 
Pituitary morphology investigation revealed structural 
abnormality of pituitary and pituitary stalk: anterior 
pituitary hypoplasia and pituitary stalk interruption (Fig. 
1 and Fig. 2). Posterior pituitary was in situ with normal 
“bright reflex” on MRI (Fig. 1).  
 
Fig. 1 Sagittal pituitary MRI showing pituitary hypoplasia 
 
Fig. 2 Coronal pituitary MRI 
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Adrenal insufficiency may result from a wide variety 
of congenital and acquired disorders of adrenal cortex, 
pituitary and hypothalamus (Table 2), adapted from Sas-
igarn and Rohan [12]. Destruction or dysfunction of the 
adrenal cortex is the cause of primary adrenal insuffi-
ciency (PAI) and its initial clinical presentation or relapse 
is frank and well known as “adrenal crisis” (AC), a medi-
cal emergency presenting as vomiting and abdominal 
complaints imitating gastrointestinal cause of dehydra-
tion. The progression could be gradual and nonspecific 
from hypotension to shock, depending on the degree of 
insufficiency and precipitating stress events. The elec-
trolyte profile is typical; hyponatremia, hypochloremia, 
hyperkalemia (usually in PAI) and hypoglycemia (in 
children) accompanied by metabolic acidosis and occa-
sionally hypercalcemia . However, it is very often misdi-
agnosed despite of well-established diagnostic criteria 
[1318]. In contrast, electrolytes in secondary adrenal 
insufficiency (SAI) are usually within normal range. The 
hypoadrenalism is therefore due to pituitary or hypotha-
lamic disorder, resulting in absence of the normal ACTH 
stimulation to the adrenal cortex. The consequence is 
partial or total cortisol deficiency but often a normal or 
near normal production of aldosterone. Mineralocorticoid 
secretion is not impaired because of primary regulation of 
aldosterone synthesis by the renin-angiotensin system 
among other stimuli. That is why it is more hidden and 
difficult to recognize. Cortisol provides some 30-50% of 
normal mineralocorticoid activity as it is present in great 
excess to aldosterone. The clinical symptoms of second-
ary adrenal insufficiency are also related to the degree of 
cortisol deficiency. The most common signs and symp-
toms are dry skin, decreased pubic/axillary hair, myalgia, 
arthralgia, severe fatigue, abdominal pain, loss of appe-
tite, weight loss, nausea, vomiting, diarrhea, muscle 
weakness, headache, irritability, and depression or de-
creased consciousness. Since aldosterone is typically not 
diminished, low blood pressure and muscle spasms are 
not so prominent and severe as they are in primary ad-
renal insufficiency. Unlike in Addison’s disease, hyper-
pigmentation does not occur [12, 15]. 
Pituitary stalk lesions (PSL) in children depicted on 
MRI investigation are rarely reported. There are only 
few clinical series published recently [1921]. Second-
ary adrenal insufficiency was the least common condi-
tion and, when present, was always associated with de-
ficiency of at least one other axis [19]. In our patient, 
documented secondary adrenal insufficiency and “cer-
tain“GH deficiency could be acquired as consequence 
of acute posttraumatic hypopituitarism (MRI of the pi-
tuitary region showed pituitary stalk interruption). Also, 
hypopituitarism could be congenital taking into account 
the MRI finding of the pituitary hypoplasia. Hamilton 
an al examined the causes of pituitary stalk lesions in 
adults and children. They noted that in adults inflam-
matory lesions were most common, while in children 
congenital lesions predominated [22]. Although, the 
MRI of the pituitary region in our patient showed only 
pituitary hypoplasia and pituitary stalk interruption, 
there were no criteria for Pituitary stalk interruption 
syndrome (PSIS). PSIS is characterized by MRI finding 
of a thin or absent pituitary stalk, associated hypoplastic 
or aplastic anterior pituitary and ectopic posterior pitui-
tary (EPP). Clinically, PSIS can be associated with 
midline defects and various pituitary endocrine defi-
ciencies, ranging from isolated growth hormone defi-
ciency (IGHD) to combined pituitary hormone defi-
ciency (CPHD). The endocrine outcome seems to be a 
progressive onset of hormone deficiencies leading to 
panhypopituitarism, but posterior pituitary function is 
usually maintained [22, 23].  
The clinical presentation of posttraumatic stalk le-
sion can be similar as in PSIS [24]. Our patient does not 
fulfill MRI criteria for PSIS, since no ectopic posterior 
pituitary was found. It was challenging to find the cause 
of hypopituitarism; congenital pituitary hypoplasia due 
to genetic mutation, posttraumatic stalk lesion, lympho-
cytic hypophysitis or all together. Unfortunately, genetic 
analysis was not available, as well as pituitary antibod-
ies determination [25]. The patient did have a history of 
the head injury. The hormonal axis most often chroni-
cally affected in patients with traumatic hypopituitarism 
Table 2 Causes of adrenal insufficiency 
Primary Adrenal Insufficiency (PAI) Secondary or Central Adrenal Insufficiency (SAI) 
1. Congenital adrenal hyperplasia (CAH)  I congenital causes 
2. Bilateral adrenal hemorrhage of the newborn 1. Septo-optic dysplasia  
(SOD), HESX1, SOX2, SOX3, OTX2 
3. Adrenal hemorrhage of acute infection 
(Waterhouse-Friderichsen syndrome) 
2. Pituitary aplasia, pituitary hypoplasia  
(LHX3, LHX4, OTX2, PROP1) 
4. Autoimmune adrenalitis (isolated or part of autoimmune 
polyglandular syndrome type 1 and 2) 
3. Mutations in gene of POMC 
(Pro-opiomelanocortin) 
5. Infection (e.g. tuberculosis, fungal infection,  
human immunodeficiency virus, cytomegalovirus)  II acquired SAI 
6. Triple A syndrome or Allgrove syndrome  
(alacrimia, achalasia, adrenal insufficiency) 
1. Trauma 
7. Adrenal unresponsiveness to ACTH due to gene mutations 2. Brain tumors  
8. Drug effects (mitotane, ketoconazole, 
aminoglutethimide, metyrapone, megestrol, rifampin) 
3. Iatrogenic causes: surgery, cranial irradiation, steroid 
withdrawal after prolonged administration  
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is the growth hormone axis. In the acute phase follow-
ing traumatic brain injury, the hormonal axes most often 
affected are the gonadotropin axis (41.6 %), the growth 
hormone axis (20.4 %), the ACTH axis (9.8 %), and the 
thyroid axis (5.8 %). ACTH production is usually a late 
function to be lost in pituitary disease and is therefore 
almost always associated with gonadotropin and GH 
deficiency. Hormonal dysfunction tends to be at least 
partially improved in up to 60 % of patients following a 
traumatic injury [26]. Detection of pituitary antibodies 
has been used to aid in the diagnosis of post traumatic 
hypopituitarism [25]. 
A genetic cause was also considered in our patient 
but couldn’t be confirmed. We did not have possibilities 
to investigate numerous genes encoding transcriptional 
factors, identified as critical for pituitary development 
during early embryonic life. Identified responsible 
genes for CPHD that includes ACTH deficiency, are 
numerous: HESX1, LHX3, LHX4, OTX2, PROP1 [10, 
27-29]. Complex interplay between congenital and envi-
ronmental factors with the influence of endogenous 
factors may result in pituitary malformation. It appears 
that pituitary talks back to hypothalamus, so that con-
nections between them are vital for normal development 
of both structures. 
To the best of our knowledge, this is the first report 
of a child with RAP caused by pituitary disorder. We 
documented the hormonal dysfunction and dysmorphic 
pituitary. The nature of the SAI in this case, congenital 
or acquired, remains to be fully elucidated. Secondary 
adrenal insufficiency usually presents as vague clinical 
symptoms with the wide range of clinical signs making 
it difficult to diagnose. Timely recognition and clinical 
management of adrenal insufficiency are critical to pre-
vent morbidity and mortality. 
Conclusion  
Adrenal insufficiency of pituitary origin was the cause 
of RAP in an 8-year-old girl mimicking the abdominal 
cause of disease. The diagnosis was late and child’s 
suffering was prolonged with possibility of negative 
outcome. We concluded that the first and more promi-
nent complaint of central adrenal insufficiency in child-
hood could be RAP, so immediate endocrine evaluation 
is mandatory. Pituitary insufficiency may evolve over 
time and children must be kept under careful endocrine 
follow-up. Untreated hormonal abnormalities could lead 
to life-threatening AC. 
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